End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.55 USD | +3.73% | +1.76% | +116.83% |
May. 16 | HC Wainwright Initiates Dianthus Therapeutics With Buy Rating, $40 Price Target | MT |
May. 10 | Wedbush Adjusts Dianthus Therapeutics' Price Target to $38 From $33, Keeps Outperform Rating | MT |
Financials (USD)
Sales 2024 * | 1.82M | Sales 2025 * | 1.98M | Capitalization | 662M |
---|---|---|---|---|---|
Net income 2024 * | -63M | Net income 2025 * | -88M | EV / Sales 2024 * | 191 x |
Net cash position 2024 * | 314M | Net cash position 2025 * | 518M | EV / Sales 2025 * | 72.5 x |
P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-8.67
x | Employees | 53 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.16% |
1 day | +3.73% | ||
1 week | +1.76% | ||
Current month | +4.35% | ||
1 month | -12.60% | ||
3 months | -9.00% | ||
6 months | +146.72% | ||
Current year | +116.83% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 22.55 | +3.73% | 122,428 |
24-06-04 | 21.74 | -0.69% | 152,252 |
24-06-03 | 21.89 | +1.30% | 178,190 |
24-05-31 | 21.61 | +4.40% | 229,868 |
24-05-30 | 20.7 | -6.59% | 154,451 |
End-of-day quote Nasdaq, June 04, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+116.83% | 662M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.43% | 22.67B | |
-9.70% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- DNTH Stock